Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Presumed tuberculous retrobulbar optic neuritis: a diagnosis challenge.

Aupy J, Vital A, Rougier MB, Gradel A, Meissner W, Marchal C, Penchet G, Brochet B.

J Neurol. 2015 Feb;262(2):481-4. doi: 10.1007/s00415-014-7611-5. Epub 2014 Dec 24. No abstract available.

PMID:
25536904
[PubMed - in process]
2.

Adult-onset genetic leukoencephalopathies: A MRI pattern-based approach in a comprehensive study of 154 patients.

Ayrignac X, Carra-Dalliere C, Menjot de Champfleur N, Denier C, Aubourg P, Bellesme C, Castelnovo G, Pelletier J, Audoin B, Kaphan E, de Seze J, Collongues N, Blanc F, Chanson JB, Magnin E, Berger E, Vukusic S, Durand-Dubief F, Camdessanche JP, Cohen M, Lebrun-Frenay C, Brassat D, Clanet M, Vermersch P, Zephir H, Outteryck O, Wiertlewski S, Laplaud DA, Ouallet JC, Brochet B, Goizet C, Debouverie M, Pittion S, Edan G, Deburghgraeve V, Le Page E, Verny C, Amati-Bonneau P, Bonneau D, Hannequin D, Guyant-Maréchal L, Derache N, Louis Defer G, Moreau T, Giroud M, Guennoc AM, Clavelou P, Taithe F, Mathis S, Neau JP, Magy L, Devoize JL, Bataillard M, Masliah-Planchon J, Dorboz I, Tournier-Lasserve E, Levade T, Boespflug Tanguy O, Labauge P.

Brain. 2015 Feb;138(Pt 2):284-92. doi: 10.1093/brain/awu353. Epub 2014 Dec 19.

PMID:
25527826
[PubMed - in process]
3.

Information processing speed impairment and cerebellar dysfunction in relapsing-remitting multiple sclerosis.

Ruet A, Hamel D, Deloire MS, Charré-Morin J, Saubusse A, Brochet B.

J Neurol Sci. 2014 Dec 15;347(1-2):246-50. doi: 10.1016/j.jns.2014.10.008. Epub 2014 Oct 12.

PMID:
25454642
[PubMed - in process]
4.

MS Lesions Are Better Detected with 3D T1 Gradient-Echo Than with 2D T1 Spin-Echo Gadolinium-Enhanced Imaging at 3T.

Crombé A, Saranathan M, Ruet A, Durieux M, de Roquefeuil E, Ouallet JC, Brochet B, Dousset V, Tourdias T.

AJNR Am J Neuroradiol. 2014 Nov 6. [Epub ahead of print]

PMID:
25376810
[PubMed - as supplied by publisher]
5.

Early predictors of multiple sclerosis after a typical clinically isolated syndrome.

Ruet A, Arrambide G, Brochet B, Auger C, Simon E, Rovira A, Montalban X, Tintoré M.

Mult Scler. 2014 Nov;20(13):1721-6. doi: 10.1177/1352458514533397. Epub 2014 May 19.

PMID:
24842960
[PubMed - in process]
6.

Radiologically isolated syndrome: 5-year risk for an initial clinical event.

Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M, Keegan BM, Donlon S, Hua le H, Vidal-Jordana A, Montalban X, Rovira A, Tintoré M, Amato MP, Brochet B, de Seze J, Brassat D, Vermersch P, De Stefano N, Sormani MP, Pelletier D, Lebrun C; Radiologically Isolated Syndrome Consortium (RISC); Club Francophone de la Sclérose en Plaques (CFSEP).

PLoS One. 2014 Mar 5;9(3):e90509. doi: 10.1371/journal.pone.0090509. eCollection 2014.

PMID:
24598783
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.

Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, Ruet A, Debouverie M, Le Page E, Casez O, Heinzlef O, Stankoff B, Bourre B, Castelnovo G, Rico A, Berger E, Camdessanche JP, Defer G, Clavelou P, Al Khedr A, Zephir H, Fromont A, Papeix C, Brochet B, Pelletier J, Lebrun C; Club Francophone de la Sclérose en Plaques Investigators.

JAMA Neurol. 2014 Apr;71(4):436-41. doi: 10.1001/jamaneurol.2013.6240.

PMID:
24566807
[PubMed - indexed for MEDLINE]
8.

[Cavitary lesions in multiple sclerosis: multicenter study on twenty patients].

Corlobé A, Renard D, Goizet C, Berger E, Rumbach L, Robinson A, Dupuy D, Touzé E, Zéphir H, Vermersch P, Brochet B, Edan G, Deburghgraeve V, Créange A, Castelnovo G, Cohen M, Lebrun-Frenay C, Boespflug-Tanguy O, Labauge P.

Rev Neurol (Paris). 2013 Dec;169(12):965-9. doi: 10.1016/j.neurol.2013.02.010. Epub 2013 Oct 17. French.

PMID:
24139243
[PubMed - indexed for MEDLINE]
9.

[Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? Yes].

Brochet B.

Rev Neurol (Paris). 2013 Nov;169(11):858-63. doi: 10.1016/j.neurol.2013.08.003. Epub 2013 Oct 2. French.

PMID:
24094530
[PubMed - indexed for MEDLINE]
10.

Probable medications overuse headaches: validation of a brief easy-to-use screening tool in a headache centre.

Dousset V, Maud M, Legoff M, Radat F, Brochet B, Dartigues JF, Kurth T.

J Headache Pain. 2013 Oct 2;14:81. doi: 10.1186/1129-2377-14-81.

PMID:
24088386
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, Zipp F, D'Alfonso S, Martinelli-Boneschi F, Taylor B, Harbo HF, Kockum I, Hillert J, Olsson T, Ban M, Oksenberg JR, Hintzen R, Barcellos LF; Wellcome Trust Case Control Consortium 2 (WTCCC2); International IBD Genetics Consortium (IIBDGC), Agliardi C, Alfredsson L, Alizadeh M, Anderson C, Andrews R, Søndergaard HB, Baker A, Band G, Baranzini SE, Barizzone N, Barrett J, Bellenguez C, Bergamaschi L, Bernardinelli L, Berthele A, Biberacher V, Binder TM, Blackburn H, Bomfim IL, Brambilla P, Broadley S, Brochet B, Brundin L, Buck D, Butzkueven H, Caillier SJ, Camu W, Carpentier W, Cavalla P, Celius EG, Coman I, Comi G, Corrado L, Cosemans L, Cournu-Rebeix I, Cree BA, Cusi D, Damotte V, Defer G, Delgado SR, Deloukas P, di Sapio A, Dilthey AT, Donnelly P, Dubois B, Duddy M, Edkins S, Elovaara I, Esposito F, Evangelou N, Fiddes B, Field J, Franke A, Freeman C, Frohlich IY, Galimberti D, Gieger C, Gourraud PA, Graetz C, Graham A, Grummel V, Guaschino C, Hadjixenofontos A, Hakonarson H, Halfpenny C, Hall G, Hall P, Hamsten A, Harley J, Harrower T, Hawkins C, Hellenthal G, Hillier C, Hobart J, Hoshi M, Hunt SE, Jagodic M, Jelčić I, Jochim A, Kendall B, Kermode A, Kilpatrick T, Koivisto K, Konidari I, Korn T, Kronsbein H, Langford C, Larsson M, Lathrop M, Lebrun-Frenay C, Lechner-Scott J, Lee MH, Leone MA, Leppä V, Liberatore G, Lie BA, Lill CM, Lindén M, Link J, Luessi F, Lycke J, Macciardi F, Männistö S, Manrique CP, Martin R, Martinelli V, Mason D, Mazibrada G, McCabe C, Mero IL, Mescheriakova J, Moutsianas L, Myhr KM, Nagels G, Nicholas R, Nilsson P, Piehl F, Pirinen M, Price SE, Quach H, Reunanen M, Robberecht W, Robertson NP, Rodegher M, Rog D, Salvetti M, Schnetz-Boutaud NC, Sellebjerg F, Selter RC, Schaefer C, Shaunak S, Shen L, Shields S, Siffrin V, Slee M, Sorensen PS, Sorosina M, Sospedra M, Spurkland A, Strange A, Sundqvist E, Thijs V, Thorpe J, Ticca A, Tienari P, van Duijn C, Visser EM, Vucic S, Westerlind H, Wiley JS, Wilkins A, Wilson JF, Winkelmann J, Zajicek J, Zindler E, Haines JL, Pericak-Vance MA, Ivinson AJ, Stewart G, Hafler D, Hauser SL, Compston A, McVean G, De Jager P, Sawcer SJ, McCauley JL.

Nat Genet. 2013 Nov;45(11):1353-60. doi: 10.1038/ng.2770. Epub 2013 Sep 29.

PMID:
24076602
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.

Schwab N, Schneider-Hohendorf T, Posevitz V, Breuer J, Göbel K, Windhagen S, Brochet B, Vermersch P, Lebrun-Frenay C, Posevitz-Fejfár A, Capra R, Imberti L, Straeten V, Haas J, Wildemann B, Havla J, Kümpfel T, Meinl I, Niessen K, Goelz S, Kleinschnitz C, Warnke C, Buck D, Gold R, Kieseier BC, Meuth SG, Foley J, Chan A, Brassat D, Wiendl H.

Neurology. 2013 Sep 3;81(10):865-71. doi: 10.1212/WNL.0b013e3182a351fb. Epub 2013 Aug 7.

PMID:
23925765
[PubMed - indexed for MEDLINE]
13.

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.

Outteryck O, Ongagna JC, Brochet B, Rumbach L, Lebrun-Frenay C, Debouverie M, Zéphir H, Ouallet JC, Berger E, Cohen M, Pittion S, Laplaud D, Wiertlewski S, Cabre P, Pelletier J, Rico A, Defer G, Derache N, Camu W, Thouvenot E, Moreau T, Fromont A, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Casez O, Hautecoeur P, Papeix C, Lubetzki C, Fontaine B, Couturier N, Bohossian N, Clanet M, Vermersch P, de Sèze J, Brassat D; BIONAT Network,; CFSEP.

Eur J Neurol. 2014;21(1):40-8. doi: 10.1111/ene.12204. Epub 2013 Jun 12.

PMID:
23895407
[PubMed - indexed for MEDLINE]
14.

How can cognitive reserve in multiple sclerosis inform clinical care?

Arnett PA, Brochet B.

Neurology. 2013 May 7;80(19):1724-5. doi: 10.1212/WNL.0b013e3182919083. Epub 2013 Apr 10. No abstract available.

PMID:
23576628
[PubMed - indexed for MEDLINE]
15.

Cognitive impairment differs between primary progressive and relapsing-remitting MS.

Ruet A, Deloire M, Charré-Morin J, Hamel D, Brochet B.

Neurology. 2013 Apr 16;80(16):1501-8. doi: 10.1212/WNL.0b013e31828cf82f. Epub 2013 Mar 20.

PMID:
23516324
[PubMed - indexed for MEDLINE]
16.

A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.

Ruet A, Deloire MS, Charré-Morin J, Hamel D, Brochet B.

Mult Scler. 2013 Oct;19(12):1665-72. doi: 10.1177/1352458513480251. Epub 2013 Mar 4.

PMID:
23459569
[PubMed - indexed for MEDLINE]
17.

Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study.

Ruet A, Deloire M, Hamel D, Ouallet JC, Petry K, Brochet B.

J Neurol. 2013 Mar;260(3):776-84. doi: 10.1007/s00415-012-6705-1. Epub 2012 Oct 19.

PMID:
23081755
[PubMed - indexed for MEDLINE]
18.

Clinical and radiological characteristics in multiple sclerosis patients with large cavitary lesions.

Renard D, Brochet B, Vukusic S, Edan G, Deburghgraeve V, Goizet C, Dupuy D, Touze E, Deschamps R, Zephyr H, Creange A, Castelnovo G, Boespflug-Tanguy O, Labauge P.

Eur Neurol. 2012;68(3):156-61. Epub 2012 Aug 14.

PMID:
22907640
[PubMed - indexed for MEDLINE]
19.

Brief International Cognitive Assessment for MS (BICAMS): international standards for validation.

Benedict RH, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, Hamalainen P, Hartung H, Krupp L, Penner I, Reder AT, Langdon D.

BMC Neurol. 2012 Jul 16;12:55. doi: 10.1186/1471-2377-12-55.

PMID:
22799620
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.

Tourdias T, Roggerone S, Filippi M, Kanagaki M, Rovaris M, Miller DH, Petry KG, Brochet B, Pruvo JP, Radüe EW, Dousset V.

Radiology. 2012 Jul;264(1):225-33. doi: 10.1148/radiol.12111416.

PMID:
22723563
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk